The groundbreaking rise of Viagra has consistently remained a symbol of pharmaceutical success, yet its position within the broader market now triggers questions about future gains. Copycat versions are diminishing patent protection , prompting worries that supporting companies significantly dependent to Viagra's once-dominant influence could be a